The MR analysis displayed significant associations between CSF metabolites and the risk of PTs. Specifically, Acetylcarnitine (c2) (OR=0.90, 95%CI: 0.83-0.97, P=0.005), Arabonate/xylonate (OR=0.65, 95 ...